Johnson & Johnson and Progressive Corporation reported strong Q2 earnings in July 2025.
1 report, 1 independent
Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson and Progressive Corporation reported strong Q2 earnings in July 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Progressive Corporation
insurance company
Nothing else this week.
Related events
- Johnson & Johnson was referenced in a recent news report concerning New York City.
- Institutional investors boosted their stake in Johnson & Johnson (JNJ) shares, highlighting the company's drug profits and balance sheet in filings with the SEC.
- Johnson & Johnson and Broadcom are noted as major holdings in the same investment fund, which also involves Apollo Global Management.
Coverage
Newest first; wire copies grouped- ZacksCompany News for Jul 17, 2025 Shares of Johnson & Johnson (JNJ) jumped 6.2% after the company reported second-quarter 2025 earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.66 p